Manzanita Pharmaceuticals is a biopharma company that develops non-opiate, pen-injectable glucocorticoids for the treatment of chronic pain. It offers Nervelight, an intra-operative nerve imaging agent that is applied topically to aid oncologic surgeons in fluorescence-guided surgery.